Pictet Asset Management (UK)’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$73.6M Buy
847,723
+108,741
+15% +$8.76M 0.08% 276
2021
Q1
$60.9M Buy
738,982
+146,729
+25% +$14.1M 0.07% 293
2020
Q4
$53.9M Sell
592,253
-725,747
-55% -$45.1M 0.07% 294
2020
Q3
$52.7M Buy
1,318,000
+20,221
+2% +$706K 0.08% 267
2020
Q2
$44.5M Buy
1,297,779
+731,467
+129% +$21.8M 0.08% 268
2020
Q1
$12.6M Sell
566,312
-667,285
-54% -$16.9M 0.03% 435
2019
Q4
$24.1M Buy
1,233,597
+112,479
+10% +$1.79M 0.04% 398
2019
Q3
$17.4M Buy
1,121,118
+775,700
+225% +$14.9M 0.04% 419
2019
Q2
$7.01M Buy
+345,418
New +$6.22M 0.02% 610

Other funds holding FATE